Tagged: Inclusive drug development

Racial and ethnic minorities make up 39% of the U.S. population, but their representation in clinical trials ranges from a mere 2% to 16%. This significant gap in clinical trial diversity raises valid concerns about medical research’s effectiveness across population groups. The numbers paint a...